1.Correlation between the occurrence of acute gastroenteritis in children and regional temperature at a tertiary hospital emergency department in Korea
Yunkoo KANG ; Sowon PARK ; Hong KOH ; Seung KIM
Pediatric Emergency Medicine Journal 2018;5(1):19-24
		                        		
		                        			
		                        			PURPOSE: Several studies have investigated the association between acute gastroenteritis (AGE) and regional temperatures. We aimed to investigate the correlation between the occurrence of AGE and regional temperature in Korean children. METHODS: We reviewed the clinical characteristics of children aged 18 years or younger with AGE, defined according to the International Statistical Classification of Diseases, 10th Revision codes, who visited a Korean tertiary hospital emergency department (ED) between 2006 and 2016, and compared the children who were discharged from the ED and those who were hospitalized. Data on temperature in Seoul, Korea during the period were obtained from the Korea Meteorological Administration. Subsequently, we assessed correlations between the monthly mean numbers of the children with AGE and monthly mean temperature using Pearson's correlation analysis.
		                        		
		                        		
		                        		
		                        			Child
		                        			;
		                        		
		                        			Child, Hospitalized
		                        			;
		                        		
		                        			Chills
		                        			;
		                        		
		                        			Classification
		                        			;
		                        		
		                        			Cough
		                        			;
		                        		
		                        			Emergencies
		                        			;
		                        		
		                        			Emergency Medicine
		                        			;
		                        		
		                        			Emergency Service, Hospital
		                        			;
		                        		
		                        			Epidemiology
		                        			;
		                        		
		                        			Fever
		                        			;
		                        		
		                        			Gastroenteritis
		                        			;
		                        		
		                        			Hospitalization
		                        			;
		                        		
		                        			Humans
		                        			;
		                        		
		                        			Korea
		                        			;
		                        		
		                        			Resource Allocation
		                        			;
		                        		
		                        			Seoul
		                        			;
		                        		
		                        			Sputum
		                        			;
		                        		
		                        			Tertiary Care Centers
		                        			;
		                        		
		                        			Vomiting
		                        			;
		                        		
		                        			Weather
		                        			
		                        		
		                        	
2.Can oliceridine (TRV130), an ideal novel µ receptor G protein pathway selective (µ-GPS) modulator, provide analgesia without opioid-related adverse reactions?
Hwoe Gyeong OK ; Su Young KIM ; Su Jung LEE ; Tae Kyun KIM ; Billy K HUH ; Kyung Hoon KIM
The Korean Journal of Pain 2018;31(2):73-79
		                        		
		                        			
		                        			All drugs have both favorable therapeutic and untoward adverse effects. Conventional opioid analgesics possess both analgesia and adverse reactions, such as nausea, vomiting, and respiratory depression. The opioid ligand binds to µ opioid receptor and non-selectively activates two intracellular signaling pathways: the G protein pathway induce analgesia, while the β-arrestin pathway is responsible for the opioid-related adverse reactions. An ideal opioid should activate the G protein pathway while deactivating the β-arrestin pathway. Oliceridine (TRV130) has a novel characteristic mechanism on the action of the µ receptor G protein pathway selective (µ-GPS) modulation. Even though adverse reactions (ADRs) are significantly attenuated, while the analgesic effect is augmented, the some residual ADRs persist. Consequently, a G protein biased µ opioid ligand, oliceridine, improves the therapeutic index owing to increased analgesia with decreased adverse events. This review article provides a brief history, mechanism of action, pharmacokinetics, pharmacodynamics, and ADRs of oliceridine.
		                        		
		                        		
		                        		
		                        			Analgesia
		                        			;
		                        		
		                        			Analgesics, Opioid
		                        			;
		                        		
		                        			Animals
		                        			;
		                        		
		                        			Bias (Epidemiology)
		                        			;
		                        		
		                        			Drug-Related Side Effects and Adverse Reactions
		                        			;
		                        		
		                        			GTP-Binding Proteins
		                        			;
		                        		
		                        			Intracellular Signaling Peptides and Proteins
		                        			;
		                        		
		                        			Ligands
		                        			;
		                        		
		                        			Mice
		                        			;
		                        		
		                        			Mice, Knockout
		                        			;
		                        		
		                        			Nausea
		                        			;
		                        		
		                        			Patient Safety
		                        			;
		                        		
		                        			Pharmacokinetics
		                        			;
		                        		
		                        			Receptors, Opioid
		                        			;
		                        		
		                        			Receptors, Opioid, mu
		                        			;
		                        		
		                        			Respiratory Insufficiency
		                        			;
		                        		
		                        			Vomiting
		                        			
		                        		
		                        	
3.Epidemiological characteristics of outbreaks of norovirus-GⅡ.2, GⅡ.17 and GⅡ.4/Sydney in Guangdong province, 2013-2017.
M ZHANG ; Y F LONG ; L M GUO ; S L WU ; L FANG ; F YANG ; H LI ; Q HUANG ; L M SUN
Chinese Journal of Epidemiology 2018;39(9):1210-1215
		                        		
		                        			
		                        			Objective: To understand the epidemiologic characteristics of outbreaks, caused by norovirus-GⅡ.2、GⅡ.17 and GⅡ.4/Sydney in Guangdong Province from 2013 to 2017 and to provide scientific evidence for epidemic prevention and control. Methods: Incidence data of norovirus outbreaks in Guangdong from January 1(st) 2013 to November 30(th) 2017 were collected from Public Health Emergency Management Information System. RT-PCR was performed for every case of each outbreak to detect norovirus nucleic acid and gene sequencing was conducted to identify the genotype of norovirus. Characteristics of norovirus GⅡ.2, GⅡ.17 and GⅡ.4/Sydney outbreaks were analyzed. Directly standardized method was used to calculate the proportion of symtoms as diarrhea and vomitting. Results: From January 1(st) 2013 to November 30(th) 2017, a total of 167 norovirus outbreaks were reported in Guangdong, and 115 outbreaks were caused by norovirus GⅡ.2, GⅡ.17 and GⅡ.4/Sydney respectively. The outbreaks caused by norovirus GⅡ.2 accounted for 39.68% (25/63) in primary schools, 28.57% (18/63) in child care settings, 25.40% (16/63) in middle schools and 6.35% (4/63) in universities. Outbreaks caused by norovirus GⅡ.17 accounted for 41.03% (16/39) in middle schools, 20.51% (8/39) at workplaces, 15.38% (6/39) in primary schools, 12.82% (5/39) in universities, 5.13% (2/39) in communities and child care settings respectively. The outbreaks caused by norovirus GⅡ.4/Sydney accounted for 53.85% (7/13) in universities, 15.38% (2/13) in child care settings and at workplaces respectively, 7.69%(1/13) in primary schools and middle schools respectively. The outbreaks caused by norovirus GⅡ.2 had 77.78% (49/63) of contact transmission, 17.46% (11/63) of food-borne transmission. The outbreaks caused by norovirus GⅡ.17 showed 53.85% (21/39) of food-borne transmission, 15.38% (6/39) of contract transmission, 12.82% (5/39) of water-borne transmission. The outbreaks caused by norovirus GⅡ.4/Sydney had 53.85% (7/13) of food-borne transmission, 38.46% (5/13) of the contact transmission. In terms of the clinical manifestations, the standardized proportion of vomit was 73.76% and the proportion of diarrhea was 42.85% in cases infected with norovirus GⅡ.2, the proportion of standardized of vomit was 76.37% and the proportion of diarrhea was 51.40% in cases infected with norovirus GⅡ.17, with the standardized proportion of vomit was 54.10% and the proportion of diarrhea was 55.95% in cases infected with norovirus GⅡ.4/Sydney. Conclusions: The outbreaks caused by norovirus GⅡ.2 through contact transmission mainly occurred in primary schools, child care settings and middle schools. The outbreaks caused by norovirus GⅡ.17 through food-borne transmission mainly occurred in middle schools and at workplaces. The outbreaks caused by norovirus GⅡ.4/Sydney food-borne transmission and contact mainly occurred in universities.
		                        		
		                        		
		                        		
		                        			Adolescent
		                        			;
		                        		
		                        			Caliciviridae Infections/epidemiology*
		                        			;
		                        		
		                        			Child
		                        			;
		                        		
		                        			Child, Preschool
		                        			;
		                        		
		                        			Diarrhea/etiology*
		                        			;
		                        		
		                        			Disease Outbreaks
		                        			;
		                        		
		                        			Epidemics
		                        			;
		                        		
		                        			Gastroenteritis/epidemiology*
		                        			;
		                        		
		                        			Genotype
		                        			;
		                        		
		                        			Humans
		                        			;
		                        		
		                        			Norovirus/isolation & purification*
		                        			;
		                        		
		                        			Reverse Transcriptase Polymerase Chain Reaction
		                        			;
		                        		
		                        			Sentinel Surveillance
		                        			;
		                        		
		                        			Vomiting/etiology*
		                        			
		                        		
		                        	
4.Laparoscopic segmental gastrectomy for early gastric cancer.
Lai XU ; Beizhan NIU ; Xiyu SUN ; Menghua DAI ; Yi XIAO
Chinese Journal of Gastrointestinal Surgery 2017;20(2):213-217
OBJECTIVETo investigate the feasibility of segmental pylorus-reservation gastrectomy in patients with early gastric cancer.
METHODA retrospective cohort study on clinical data of 6 patients strictly met the criteria of early gastric cancer locating in the middle of the stomach undergoing laparoscopic segmental gastrectomy from January 2014 to April 2016 at Department of General Surgery, Peking Union Medical College Hospital was carried out. Preoperative clinical staging revealed T1N0M0 for all the cases. One case received endoscopic mucosa resection(EMR) first, and postoperative pathology showed moderate differentiated adenocarcinoma invading substratum of mucosa, so a complementary laparoscopic segmental gastrectomy was performed. Surgical procedure was laparoscopic segmental gastrectomy with D1 or D2 lymph node dissection. Vagus nerve was not reserved during lymph node dissection in lesser curvature side. Number of resected lymph node, postoperative complication and long-term gastric function were observed.
RESULTOf 6 cases, 3 were male and 3 were female with age ranging from 55 to 59 years old. The distal resection margin was (4.6±0.5) cm away from pylorus. The average number of resected lymph node was 18.3±7.5 without metastasis. Follow-up time was 1 to 29 months for all the 6 cases and no relapse or metastasis was found during the follow-up. In 4 cases with follow-up beyond 1 year, 3 cases had slight distension in superior belly after meal and dyspepsia; another one case had vomiting nocturnal occasionally. Gastroscope examination one year after operation found food residue in all the cases. Images indicated the decrease of stomach size in all the cases. Two cases had esophagogastric reflux. All the patients had delayed gastric emptying symptoms after operations and were relieved within one year.
CONCLUSIONSIt is technically feasible to perform laparoscopic segmental gastrectomy in patients with early gastric cancer. Whether vagus nerve should be reserved requires further investigation.
Female ; Gastrectomy ; adverse effects ; methods ; Gastroesophageal Reflux ; epidemiology ; etiology ; Gastroparesis ; epidemiology ; etiology ; Humans ; Laparoscopy ; adverse effects ; methods ; Lymph Node Excision ; adverse effects ; methods ; statistics & numerical data ; Male ; Middle Aged ; Neoplasm Staging ; Postoperative Complications ; epidemiology ; etiology ; Retrospective Studies ; Stomach Neoplasms ; surgery ; Treatment Outcome ; Vagus Nerve ; surgery ; Vomiting ; epidemiology ; etiology
5.Clinical Characteristics of Pertussis Epidemic in Changwon.
Joon Weon JANG ; Jin Han KANG ; Jae Won CHOI ; Hak Sung LEE ; Sang Hyuk MA
Pediatric Infection & Vaccine 2017;24(1):37-43
		                        		
		                        			
		                        			PURPOSE: Pertussis can be prevented with a vaccine. Despite this, there have been an increasing number of cases worldwide, and also in Korea. This study aimed to investigate the epidemiology and clinical characteristics of the recent outbreak in the Changwon area. METHODS: Patients who visited Changwon Fatima Hospital from July 2015 to March 2016 with respiratory symptoms, including spasmodic cough, cough induced vomiting, inspiratory ‘intake’ sound (whooping), and a night-time cough for >1 week were included in this study. Respiratory specimens were collected from patients and a polymerase chain reaction (PCR) and detected anti-pertussis immunoglobulin G enzyme-linked immunosorbent assay kit test were performed. Patients with underlying diseases, or those who had received a DTaP or Tdap vaccination in recent 1 year were excluded. RESULTS: Pertussis was diagnosed in 37 of 50 patients, two patients were positive according to the PCR, and 37 patients were positive according to serologic tests. The age distribution of the patients was 1 month to 15 years. After administering antibiotics, all patients recovered without complications. CONCLUSIONS: A pertussis outbreak occurred in Changwon in 2015 and 2016. This data can provide the basis for further study on the epidemiology of pertussis in Korea.
		                        		
		                        		
		                        		
		                        			Age Distribution
		                        			;
		                        		
		                        			Anti-Bacterial Agents
		                        			;
		                        		
		                        			Cough
		                        			;
		                        		
		                        			Enzyme-Linked Immunosorbent Assay
		                        			;
		                        		
		                        			Epidemiology
		                        			;
		                        		
		                        			Gyeongsangnam-do*
		                        			;
		                        		
		                        			Humans
		                        			;
		                        		
		                        			Immunoglobulin G
		                        			;
		                        		
		                        			Korea
		                        			;
		                        		
		                        			Polymerase Chain Reaction
		                        			;
		                        		
		                        			Serologic Tests
		                        			;
		                        		
		                        			Vaccination
		                        			;
		                        		
		                        			Vomiting
		                        			;
		                        		
		                        			Whooping Cough*
		                        			
		                        		
		                        	
6.Clinical analysis for patients with continuous ambulatory peritoneal dialysis associated peritonitis.
Jian LIU ; Xun HUANG ; Yao LIU ; Hui XU ; Rui'e GONG ; Chunhui LI
Journal of Central South University(Medical Sciences) 2016;41(12):1328-1333
		                        		
		                        			
		                        			To analyze the clinical characteristics of continuous ambulatory peritoneal dialysis (CAPD) associated peritonitis in the tertiary hospitals and to discuss the preventive and therapeutic strategy.
 Methods: The clinical characteristics, pathogens, resistance and outcomes of 126 CAPD associated peritonitis in 104 patients from Jan, 2013 to June, 2016, were retrospectively analyzed.
 Results: Among the patients, the incidence rates of abdominal pain, fever, diarrhea and emesis were 104 (82.54%), 56 (44.44%), 49 (38.89%), and 31 (23.60%), respectively. Among them, 88 patients suffered peritonitis once, other 16 patients suffered multiple peritonitis or recurrent peritonitis for 38 times. Among the 38 times, the numbers for recurrent, repeated or catheter-associated peritonitis were 2, 2, or 3, respectively. Peritoneal fluids from 103 cases were cultured, and 64 cases were positive in bacteria, with a rate of 62.14%. A total of 70 strains of bacteria were separated, including 42 strains of gram-positive bacteria, 21 strains of gram-negative bacteria, and 7 strains of fungus. The most common gram-positive pathogens were Staphylococcus epidermidis, Enterococcus faecalis and Staphylococcus haemolyticus, while Escherichia coli, Klebsiella pneumoniae and Klebsiella pneumoniae were the most common gram-negative bacteria. Candida albicans was the major fungal pathogens. Gram-positive cocci showed resistance to gentamycin, levofloxacin, moxifloxacin, vancomycin and linezolid, with a rate at 20.00%, 36.11%, 5%, 0%, and 0%, respectively. The gram-negative bacilli were resistent to cefoperazone/sulbactam, gentamycin, cephazolin, and ceftazidime, with a rate at 6.25%, 10.53%, 64.29%, and 15.38%, respectively. There were no imipenem, amikacin, piperacillin/tazobactam-resistant strains were found.
 Conclusion: The most common pathogen causing CAPD associated peritonitis is gram-positive bacteria. It is crucial to take the anti-infection therapy for CAPD associated peritonitis early. The positive rates for bacterial culture need to be enhanced through improvement of methods. At the same time, doctors could improve the outcome of CAPD associated peritonitis by adjusting the medication according to the drug sensitivity results.
		                        		
		                        		
		                        		
		                        			Abdominal Pain
		                        			;
		                        		
		                        			epidemiology
		                        			;
		                        		
		                        			Anti-Bacterial Agents
		                        			;
		                        		
		                        			Bacteria
		                        			;
		                        		
		                        			Bacterial Infections
		                        			;
		                        		
		                        			epidemiology
		                        			;
		                        		
		                        			microbiology
		                        			;
		                        		
		                        			Candidiasis
		                        			;
		                        		
		                        			epidemiology
		                        			;
		                        		
		                        			Catheters
		                        			;
		                        		
		                        			adverse effects
		                        			;
		                        		
		                        			microbiology
		                        			;
		                        		
		                        			Diarrhea
		                        			;
		                        		
		                        			epidemiology
		                        			;
		                        		
		                        			Drug Resistance, Bacterial
		                        			;
		                        		
		                        			Enterococcus faecalis
		                        			;
		                        		
		                        			Escherichia coli
		                        			;
		                        		
		                        			Fever
		                        			;
		                        		
		                        			epidemiology
		                        			;
		                        		
		                        			Gram-Negative Bacteria
		                        			;
		                        		
		                        			Gram-Positive Bacteria
		                        			;
		                        		
		                        			Humans
		                        			;
		                        		
		                        			Imipenem
		                        			;
		                        		
		                        			Klebsiella pneumoniae
		                        			;
		                        		
		                        			Microbial Sensitivity Tests
		                        			;
		                        		
		                        			Mycoses
		                        			;
		                        		
		                        			epidemiology
		                        			;
		                        		
		                        			Penicillanic Acid
		                        			;
		                        		
		                        			analogs & derivatives
		                        			;
		                        		
		                        			Peritoneal Dialysis
		                        			;
		                        		
		                        			Peritoneal Dialysis, Continuous Ambulatory
		                        			;
		                        		
		                        			adverse effects
		                        			;
		                        		
		                        			Peritonitis
		                        			;
		                        		
		                        			complications
		                        			;
		                        		
		                        			epidemiology
		                        			;
		                        		
		                        			microbiology
		                        			;
		                        		
		                        			Piperacillin
		                        			;
		                        		
		                        			Piperacillin, Tazobactam Drug Combination
		                        			;
		                        		
		                        			Recurrence
		                        			;
		                        		
		                        			Retrospective Studies
		                        			;
		                        		
		                        			Staphylococcus epidermidis
		                        			;
		                        		
		                        			Staphylococcus haemolyticus
		                        			;
		                        		
		                        			Vomiting
		                        			;
		                        		
		                        			epidemiology
		                        			
		                        		
		                        	
7.Association of 5-HT3B Receptor Gene Polymorphisms with the Efficacy of Ondansetron for Postoperative Nausea and Vomiting.
Min Soo KIM ; Jeong Rim LEE ; Eun Mi CHOI ; Eun Ho KIM ; Seung Ho CHOI
Yonsei Medical Journal 2015;56(5):1415-1420
		                        		
		                        			
		                        			PURPOSE: Postoperative nausea and vomiting (PONV) is a common problem after general anesthesia. Although 5-hydroxytryptamine type 3 (5-HT3) receptor antagonists have significantly reduced PONV, over 35% of patients treated with ondansetron can experience PONV. In this study, we investigated whether the Y129S and -100_-102AAG deletion polymorphisms of the 5-HT3B receptor gene affect the efficacy of ondansetron in preventing PONV. MATERIALS AND METHODS: Two hundred and forty-five adult patients who underwent laparoscopic cholecystectomy were enrolled. Ondansetron 0.1 mg/kg was intravenously administered 30 minutes before the end of surgery. Genomic DNA was prepared from blood samples using a nucleic acid isolation device. Both the Y129S variant and the -100_-102AAG deletion variant were screened for using a single base primer extension assay and a DNA direct sequencing method, respectively. The relationship between genetic polymorphisms and clinical outcomes of ondansetron treatment was investigated. RESULTS: Among the 5-HT3B AAG deletion genotypes, the incidence of PONV was higher in patients with the homomutant than with other genotypes during the first 2 hours after surgery (p=0.02). There were no significant differences in the incidence of PONV among genotypes at 2-24 hours after surgery. In the Y129S variants of the 5-HT3B receptor gene, there were no significant differences in the incidence of PONV among genotypes during the first 2 hours and at 2-24 hours after surgery. CONCLUSION: The response to ondansetron for PONV was significantly influenced by the -100_-102AAG deletion polymorphisms of the 5-HT3B gene. Thus, the -100_-102AAG deletion variants may be a pharmacogenetic predictor for responsiveness to ondansetron for PONV.
		                        		
		                        		
		                        		
		                        			Adult
		                        			;
		                        		
		                        			Aged
		                        			;
		                        		
		                        			Anesthesia, General
		                        			;
		                        		
		                        			Antiemetics/administration & dosage/*pharmacology
		                        			;
		                        		
		                        			Cholecystectomy, Laparoscopic
		                        			;
		                        		
		                        			Female
		                        			;
		                        		
		                        			Genome, Human
		                        			;
		                        		
		                        			Genotype
		                        			;
		                        		
		                        			Humans
		                        			;
		                        		
		                        			Incidence
		                        			;
		                        		
		                        			Injections, Intravenous
		                        			;
		                        		
		                        			Male
		                        			;
		                        		
		                        			Middle Aged
		                        			;
		                        		
		                        			Ondansetron/administration & dosage/*pharmacology
		                        			;
		                        		
		                        			Polymorphism, Genetic
		                        			;
		                        		
		                        			Postoperative Nausea and Vomiting/chemically induced/*drug therapy/epidemiology
		                        			;
		                        		
		                        			Receptors, Serotonin, 5-HT3/*drug effects/*genetics
		                        			;
		                        		
		                        			Time Factors
		                        			
		                        		
		                        	
8.Porcine epidemic diarrhea: a review of current epidemiology and available vaccines.
Daesub SONG ; Hyoungjoon MOON ; Bokyu KANG
Clinical and Experimental Vaccine Research 2015;4(2):166-176
		                        		
		                        			
		                        			Porcine epidemic diarrhea virus (PEDV), an Alphacoronavirus in the family Coronaviridae, causes acute diarrhea, vomiting, dehydration, and high mortality rates in neonatal piglets. PEDV can also cause diarrhea, agalactia, and abnormal reproductive cycles in pregnant sows. Although PEDV was first identified in Europe, it has resulted in significant economic losses in many Asian swine-raising countries, including Korea, China, Japan, Vietnam, and the Philippines. However, from April 2013 to the present, major outbreaks of PEDV have been reported in the United States, Canada, and Mexico. Moreover, intercontinental transmission of PEDV has increased mortality rates in seronegative neonatal piglets, resulting in 10% loss of the US pig population. The emergence and re-emergence of PEDV indicates that the virus is able to evade current vaccine strategies. Continuous emergence of multiple mutant strains from several regions has aggravated porcine epidemic diarrhea endemic conditions and highlighted the need for new vaccines based on the current circulating PEDV. Epidemic PEDV strains tend to be more pathogenic and cause increased death in pigs, thereby causing substantial financial losses for swine producers. In this review, we described the epidemiology of PEDV in several countries and present molecular characterization of current strains. We also discuss PEDV vaccines and related issues.
		                        		
		                        		
		                        		
		                        			Asian Continental Ancestry Group
		                        			;
		                        		
		                        			Canada
		                        			;
		                        		
		                        			China
		                        			;
		                        		
		                        			Coronaviridae
		                        			;
		                        		
		                        			Dehydration
		                        			;
		                        		
		                        			Diarrhea*
		                        			;
		                        		
		                        			Disease Outbreaks
		                        			;
		                        		
		                        			Epidemiology*
		                        			;
		                        		
		                        			Europe
		                        			;
		                        		
		                        			Genetics
		                        			;
		                        		
		                        			Humans
		                        			;
		                        		
		                        			Japan
		                        			;
		                        		
		                        			Korea
		                        			;
		                        		
		                        			Mexico
		                        			;
		                        		
		                        			Mortality
		                        			;
		                        		
		                        			Philippines
		                        			;
		                        		
		                        			Porcine epidemic diarrhea virus
		                        			;
		                        		
		                        			Swine
		                        			;
		                        		
		                        			United States
		                        			;
		                        		
		                        			Vaccines*
		                        			;
		                        		
		                        			Vietnam
		                        			;
		                        		
		                        			Vomiting
		                        			
		                        		
		                        	
9.The 2013-2015 Ebola outbreak in West Africa.
Ji Hoon KANG ; Weon Young CHANG ; Sungwook CHOI ; Joseph RHO ; Keun Hwa LEE
Journal of Bacteriology and Virology 2015;45(4):304-313
		                        		
		                        			
		                        			Zaire Ebola virus (EBOV) is a fatal human pathogen, with a high case fatality rate (CFR) averaging up to 78%. In March 2014, the World Health Organization (WHO) was made aware of a ZEBOV outbreak in rural Guinea, West Africa. Epidemiologic investigation linked the clinical and laboratory confirmed cases with the presumed first fatality of the outbreak in December 2013. EBOV from Guinea is a separate clade from other ZEBOV strains reported from the Democratic Republic of Congo (DRC) and Gabon. Since the outbreak in March, ZEBOV was also reported in Conakry, Guinea's capital and spread to other neighboring countries. In its largest outbreak, ZEBOV disease expanded through Guinea, Liberia, Sierra Leone, and Nigeria and to Spain, the USA, and the UK. The WHO declared the 2013-2015 West African Ebola epidemic a public health emergency of international concern considering its presumable capacity for further international spread. Early manifestations of EVD (Ebola virus disease) include a high fever, body aches, malaise, and fatigue. Severe diarrhea and other gastrointestinal manifestations such as vomiting were common, while bleeding was a more sporadic finding. The fatality rate was 43% and highest in patients aged > or = 45 years and the overall fitted mean incubation period was 10.3 days (95% CI 9.9~10.7). We present a review of the literature on the emergence of Ebola, and the epidemiologic, clinical, and laboratory records of patients in whom EVD was diagnosed in Sierra Leone, Guinea, Liberia, Mali, the USA, and Spain, its zoonotic origin, and the transmission of ZEBOV, as well as presenting original literature on the current Ebola outbreak.
		                        		
		                        		
		                        		
		                        			Africa, Western*
		                        			;
		                        		
		                        			Congo
		                        			;
		                        		
		                        			Diarrhea
		                        			;
		                        		
		                        			Ebolavirus
		                        			;
		                        		
		                        			Emergencies
		                        			;
		                        		
		                        			Epidemiology
		                        			;
		                        		
		                        			Fatigue
		                        			;
		                        		
		                        			Fever
		                        			;
		                        		
		                        			Gabon
		                        			;
		                        		
		                        			Guinea
		                        			;
		                        		
		                        			Hemorrhage
		                        			;
		                        		
		                        			Humans
		                        			;
		                        		
		                        			Liberia
		                        			;
		                        		
		                        			Mali
		                        			;
		                        		
		                        			Mortality
		                        			;
		                        		
		                        			Nigeria
		                        			;
		                        		
		                        			Public Health
		                        			;
		                        		
		                        			Sierra Leone
		                        			;
		                        		
		                        			Spain
		                        			;
		                        		
		                        			Vomiting
		                        			;
		                        		
		                        			World Health Organization
		                        			
		                        		
		                        	
10.Safety Results of Docetaxel-(Taxotere(R))-Based Chemotherapy in Early Breast Cancer Patients of Asia-Pacific Region: Asia-Pacific Breast Initiative II.
Sung Bae KIM ; Yau Tsz KOK ; Tran Van THUAN ; Tsu Yi CHAO ; Zhen Zhou SHEN
Journal of Breast Cancer 2015;18(4):356-364
		                        		
		                        			
		                        			PURPOSE: The goal of this registry was to collect patient characteristics and safety data from patients from the Asia-Pacific region with early breast cancer receiving adjuvant chemotherapy containing docetaxel (Taxotere(R)). METHODS: This registry was open-label, international, longitudinal, multicenter, and observational in design and included a prospective group of consecutive early breast cancer patients with an intermediate-to-high risk of recurrence being treated with various docetaxel-based (anthracycline and non-anthracycline) adjuvant chemotherapy regimens during 2009-2013 in real-world clinical settings. RESULTS: The analysis included 1,712 patients, 79% of whom received docetaxel-based, anthracycline-containing regimens, while 21% received non-anthracycline-containing regimens. Patients receiving adjuvant docetaxel-based chemotherapy were followed for 1.5 years. Chemotherapy-related adverse events (AEs) were reported by 76.2% of patients (anthracycline-containing vs. non-anthracycline-containing regimens: 76.8% vs. 74.1%). Serious AEs were reported in 12% of patients (12.3% vs. 10%). National Cancer Institute Common Terminology Criteria for Adverse Events grade 3 or higher neutropenia was reported in 20% of patients (21.6% vs. 13.9%), leukopenia in 7.4% of patients (5.4% vs. 14.8%), and vomiting in 1.6% of patients (1.8% vs. 0.6%). Treatment-related death was reported in 27 patients (1.6%), while only 3% of patients had a relapse. Low-density lipoprotein cholesterol/high-density lipoprotein cholesterol (HDL-C) and total cholesterol/HDL-C ratios increased after chemotherapy. A clinically insignificant reduction of 1.9% in left ventricular ejection fraction, from 66.43 to 64.53, was observed 1.5 years after therapy was completed. CONCLUSION: The Asia-Pacific Breast initiative II registry identified a variety of important facts regarding patient population characteristics, disease epidemiology and treatment response for early breast cancer patients of the Asia-Pacific region receiving docetaxel-based chemotherapy. Docetaxel-based chemotherapy did not show any significant safety concerns for early breast cancer patients of the Asia-Pacific region, and thus may represent a safe adjuvant chemotherapy regimen for these patients.
		                        		
		                        		
		                        		
		                        			Breast Neoplasms*
		                        			;
		                        		
		                        			Breast*
		                        			;
		                        		
		                        			Chemotherapy, Adjuvant
		                        			;
		                        		
		                        			Cholesterol
		                        			;
		                        		
		                        			Drug Therapy*
		                        			;
		                        		
		                        			Epidemiology
		                        			;
		                        		
		                        			Humans
		                        			;
		                        		
		                        			Leukopenia
		                        			;
		                        		
		                        			Lipoproteins
		                        			;
		                        		
		                        			National Cancer Institute (U.S.)
		                        			;
		                        		
		                        			Neutropenia
		                        			;
		                        		
		                        			Population Characteristics
		                        			;
		                        		
		                        			Prospective Studies
		                        			;
		                        		
		                        			Recurrence
		                        			;
		                        		
		                        			Registries
		                        			;
		                        		
		                        			Stroke Volume
		                        			;
		                        		
		                        			Vomiting
		                        			
		                        		
		                        	
            
Result Analysis
Print
Save
E-mail